Coastline Trust’s GSK GSK Stock Holding History

Coastline Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-7,320	Closed	-$344K	–	321
2020 Q3	$344K	Buy	7,320 +916	+14%	+$45.9K	0.05%	259
2020 Q2	$326K	Sell	6,404 -304	-5%	-$15.6K	0.05%	261
2020 Q1	$318K	Sell	6,708 -104	-2%	-$5.55K	0.06%	256
2019 Q4	$400K	Sell	6,812 -184	-3%	-$10.2K	0.06%	265
2019 Q3	$373K	Buy	6,996 +1,568	+29%	+$80.7K	0.05%	269
2019 Q2	$272K	Buy	5,428 +1,032	+23%	+$51.8K	0.04%	290
2019 Q1	$229K	Hold	4,396	–	–	0.03%	299
2018 Q4	$210K	Sell	4,396 -2,032	-32%	-$100K	0.04%	290
2018 Q3	$323K	Buy	6,428 +732	+13%	+$37.2K	0.05%	287
2018 Q2	$287K	Buy	+5,696	New	+$287K	0.04%	295
2017 Q3	–	Sell	-3,764	Closed	-$202K	–	296
2017 Q2	$202K	Buy	+3,764	New	+$201K	0.04%	281

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Coastline Trust's GSK Position: Q4 2020 in Review

Coastline Trust sold out of GSK (GSK) in Q4 2020, closing a stake of 7,320 shares — an estimated $344K sold.

Coastline Trust first reported a position in GSK in Q2 2017 and held it in 11 quarters. The position peaked at $400K in Q4 2019. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Coastline Trust reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Coastline Trust sold 7,320 GSK shares in Q4 2020, an estimated $344K.
Coastline Trust first reported a position in GSK in Q2 2017 and held it in 11 quarters.
Coastline Trust's GSK position peaked at $400K in Q4 2019.
819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Coastline Trust's 13F filing for Q4 2020, filed 12 Feb 2021.